Submission Details

Submitter:

Classification:
Definitive
GENCC:100001
Gene:
Disease:
complex hereditary spastic paraplegia
Mode Of Inheritance:
Autosomal recessive
Evaluated Date:
11/20/2023
Evidence/Notes:

MAG encodes a transmembrane, cell adhesion molecule in the periaxonal layer of mature, non-compact myelin membranes, and maintains myelin-axon spacing by interacting with specific neuronal glycolipids (gangliosides) (PMIDs: 26179919; 27922006).

MAG was first reported in relation to ‘complex’ autosomal recessive hereditary spastic paraplegia (HSP) in 2014 (PMID: 26179919). Hereditary spastic paraplegia refers to a group of inherited disorders that are characterised by progressive weakness and spasticity of the lower limbs. The term ‘complex’ is included as all individuals presented with additional neurological phenotypes such as ataxia, eye phenotypes, cognitive impairments, and vibratory sense deficits. Age of onset was typically in infancy and early childhood. Symptoms were slowly progressive and can sometimes present early as a static clinical course.

Ten variants (missense and nonsense) have been reported in 8 families in 5 publications. We have included 6 probands and 7 variants in this curation (PMIDs: 26179919, 32629324, 27606346). More evidence is available in the literature, but the maximum score for genetic evidence (12 pts) had been reached (additional PMID: 24482476, 31402626). There was no functional evidence for any of the nonsense variants; however, functional evidence for two missense variants were included in the curation. The p.Ser133Arg variants showed accumulation of terminally misfolded proteins in the endoplasmic reticulum leading to their degradation (PMID: 26179919), and p.Arg118Ala/Asp variants demonstrated loss of activity of a highly conserved sialic acid binding site (PMID: 9298990). These studies support the assumption that variants in MAG are responsible for the patients’ phenotypes by acting through a loss of protein function activity.

This gene-disease relationship is further supported by a MAG knockout murine model (PMID: 34546337). The gene was disrupted by insertion of PGK-neo cassette into exon 5. Absence of gene expression was confirmed by Western blot analysis of brains from 26-day-old homozygous mutant mice. Mice showed abnormal Schwann cell morphology, abnormal axon morphology, axon degeneration, and demyelination.

In summary, there is a definitive relationship between MAG and autosomal recessive complex HSP. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the ClinGen Cerebral Palsy Gene Curation Expert Panel on 20th November, 2023 (SOP Version 9).

PubMed IDs:
7539694 26179919 27606346 32629324
Public Report:
Assertion Criteria:
Submitter Submitted Date:
12/05/2025

The GenCC data are available free of restriction under a CC0 1.0 Universal (CC0 1.0) Public Domain Dedication. The GenCC requests that you give attribution to GenCC and the contributing sources whenever possible and appropriate. The accepted Flagship manuscript is now available from Genetics in Medicine (https://www.gimjournal.org/article/S1098-3600(22)00746-8/fulltext).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. The GenCC does not independently verify the submitted information. Though the information is obtained from sources believed to be reliable, no warranty, expressed or implied, is made regarding accuracy, adequacy, completeness, reliability or usefulness of any information. This disclaimer applies to both isolated and aggregate uses of the information. The information is provided on an "as is" basis, collected through periodic submission and therefore may not represent the most up-to-date information from the submitters. If you have questions about the medical relevance of information contained on this website, please see a healthcare professional; if you have questions about specific gene-disease claims, please contact the relevant sources; and if you have questions about the representation of the data on this website, please contact gencc@thegencc.org.